Immunoassay Market worth $ 40.21 Billion, Globally, by 2028 at 5.55% CAGR: Verified Market Research™

JERSEY CITY, N.J., June 3, 2021 /PRNewswire/ -- Verified Market Research recently published a report, "Immunoassay Market" By Product (Reagents and Kits and Analyzers), Specimen (Urine, Blood, Saliva, & others), By Application (Cardiology, Blood Screening, Autoimmune Disorders & Others), By Technology (ELISA, Rapid Tests, Radio-Immuno Assay, Western Blotting), By End User (Research & Academic Laboratories, Home Care Settings, Pharmaceutical and Biotechnology Companies & CROs), and By Geography. According to Verified Market Research, the Global Immunoassay Market was valued at USD 26.11 Billion in 2020 and is projected to reach USD 40.21 Billion by 2028, growing at a CAGR of 5.55% from 2021 to 2028.

Download PDF Brochure: https://www.verifiedmarketresearch.com/download-sample/?rid=23973

Browse in-depth TOC on "Immunoassay Market"

202 - Pages
126 – Tables
|37 – Figures

Global Immunoassay Market Overview

An important driver for growth of the Global Immunoassay market is the rise in the incidences of chronic diseases. Prevalent cases of total CVD approximately doubled from 271 million in 1990 to 523 million in 2019, and the number of CVD deaths increased from 12.1 million in 1990, reaching 18.6 million in 2019. As of May 2021, there are an estimated 100-400 million cases of dengue infections each year. According to WHO, in 2019, an estimated 10 million people fell ill with tuberculosis (TB) worldwide. 5.6 million Men, 3.2 million women and 1.2 million children. TB is present in all countries and age groups. The increasing number of these diseases calls for effective ways to diagnose them in an economical manner, which in turn is responsible for the expanding of Global Immunoassay Market.

COVID-19 has also had a significant impact on the growth of the Immunoassay Market. Exponentially increasing cases of COVID 19 worldwide has led to a need of reliable Immunoassay kits, for testing purposes, which has led to a rise in demand of the Global Immunoassay market. Additionally, technological advancements which increase the efficiency of Immunoassay in terms of cost and performance, such as the design of immunochemical approaches that brings advantages observed with larger molecular analytes with small molecules such as metabolites and toxins are responsible for the growth of the market.

Key Developments in Immunoassay Market

• Thermo Fisher Scientific Inc. acquired the private point-of-care molecular diagnostic company Mesa Biotech in February 2021.
• Abbott received the CE Mark for its Panbio COVID-19 Ag Rapid Test Device in January 2021, for the asymptomatic diagnosis of the SARS-CoV-2 virus
• Beckman Coulter, a part of Danaher (US) company, launched the first high-quality and throughput assay named Access SARS-CoV-2 Antigen assay, for the COVID-19 antigen diagnosis, in the US in December 2020.

The major players in the market are WAK-Chemie Medical GmbH, Merk KGaA, J. Mitra & Co. Pvt. Ltd., Becton, Dickinson & Company, Kamiya Biomedical Company, Siemens Healthineers, Danaher Corporation, Agilent Technologies, Inc., Tosoh Corporation, Gyros Protein Technologies among others.

Verified Market Research has segmented the Global Immunoassay Market On the basis of Product, Specimen, Application, Technology, End User and Geography.

• Immunoassay Market by Product
• Reagents and Kits
• Analyzers
• Software and Services
• Immunoassay Market by Specimen
• Urine
• Blood
• Saliva
• Other Specimens
• Immunoassay Market by Application
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Others Applications
• Immunoassay Market by Technology
• ELISA
• Rapid Tests
• Radio-Immuno Assay
• Western Blotting
• Enzyme-Linked Immunospot
• Other Technologies
• Immunoassay Market by End User
• Research & Academic Laboratories
• Home Care Settings
• Pharmaceutical and Biotechnology Companies & CROs
• Blood Banks
• Hospitals and Clinics
• Clinical Laboratories
• Immunoassay Market by Geography
• North America
• U.S
• Canada
• Mexico
• Europe
• Germany
• France
• U.K
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• ROW
• Middle East & Africa
• Latin America

Browse Related Reports:

Syphilis Immunoassay Diagnostics Market by Product (Analyzers, Reagents, Kits, and Others), by Technology (Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), and Others), by End-User (Hospitals, Blood Banks, Diagnostics Labs, and Others), by Geography, Forecast, 2020-2027

HIV/AIDS Immunoassay Diagnostics Market by Product (Consumables And Instruments), by Test Type (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, & Tests for Viral Identification), by End User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings & Other End Users), by Geography, Forecast, 2020-2027

Chemiluminescence Immunoassay (CLIA) Analyzers Market by Product Type (Analyzers, Reagents, and Consumables), by Applications (Endocrine Disorders, Oncology, Infectious Diseases, Cardiovascular Disorders, and Others), by End User (Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Industries, and Others), by Geography, Forecast, 2020-2027

Immuno Oncology Assays Market by Product (Consumables, Software and Services, and Instruments), by Technology (PCR, Flow Cytometry, Immunoassay, Next-Generation Sequencing and In Situ Hybridization), by Indication (Lung Cancer, Breast Cancer, Colorectal Cancer, Bladder Cancer, Melanoma and Other Cancers), by Application (Research Applications and Clinical Diagnostics), by Geography, Forecast, 2020-2027

Top 10 microfluidic immunoassay companies restructuring medical testing processes worldwide

Visualize Immunoassay Market using Verified Market Intelligence:-:

Verified Market Intelligence is our BI Enabled Platform for narrative storytelling of this market. VMI offers in-depth forecasted trends and accurate Insights on over 20,000+ emerging & niche markets, helping you make critical revenue impacting decisions for a brilliant future.

VMI provides a holistic overview and global competitive landscape with respect to Region, Country, and Segment, and Key players of your market. Present your Market Report & findings with an inbuilt presentation feature saving over 70% of your time and resources for Investor, Sales & Marketing, R&D, and Product Development pitches. VMI enables data delivery In Excel and Interactive PDF formats with over 15+ Key Market Indicators for your market.

About Us

Verified Market Research is a leading Global Research and Consulting firm servicing over 5000+ customers. Verified Market Research provides advanced analytical research solutions while offering information enriched research studies. We offer insight into strategic and growth analyses, Data necessary to achieve corporate goals and critical revenue decisions.

Our 250 Analysts and SME's offer a high level of expertise in data collection and governance use industrial techniques to collect and analyze data on more than 15,000 high impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise and years of collective experience to produce informative and accurate research.

We study 14+ categories from Semiconductor & Electronics, Chemicals, Advanced Materials, Aerospace & Defense, Energy & Power, Healthcare, Pharmaceuticals, Automotive & Transportation, Information & Communication Technology, Software & Services, Information Security, Mining, Minerals & Metals, Building & construction, Agriculture industry and Medical Devices from over 100 countries.

Contact Us

Mr. Edwyne Fernandes
Verified Market Research
US: +1 (650)-781-4080
UK: +44 (753)-715-0008
APAC: +61 (488)-85-9400
US Toll Free: 1 (800)-782-1768
Email: [email protected]
Web: https://www.verifiedmarketresearch.com/
Follow Us: LinkedIn | Twitter

SOURCE Verified Market Research